ArticleRSC advances2023

Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity.

Manar G Salem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.